Geo News
Community curated by people like you
LatestAICryptoHealthWorld AffairsUS Politics

Women's health stories

Aug 14, 2026

Women taking estrogen-only hormone therapy showed fewer Alzheimer's signs in brain tissue

A large study of over 2,000 women found those who used estrogen-only hormone therapy later in life were less likely to develop dementia and showed fewer signs of Alzheimer's disease in their brains upon autopsy.

Aug 14, 2026·3 sources
00
Jul 24, 2026

Genetic breakthrough reveals hidden causes of severe morning sickness in pregnancy

Scientists have identified major genetic factors underlying hyperemesis gravidarum, the severe pregnancy nausea and vomiting condition that affects some women.

Jul 24, 2026·1 source
00
Jul 16, 2026

Second pregnancy rewires brain differently than first, study finds

Researchers discovered that each pregnancy brings distinct patterns of brain changes, with second pregnancies causing different neural rewiring than first pregnancies. The findings could improve understanding of maternal brain health.

Jul 16, 2026·1 source
00
Jul 10, 2026

EU Regulator Warns Desogestrel and Etonogestrel Contraceptives Carry Small Brain Tumor Risk

The European Medicines Agency safety committee announced that commonly used contraceptives containing desogestrel and etonogestrel carry a small increased risk of meningioma after prolonged use.

Jul 10, 2026·1 source
00
Apr 25, 2026

Sudden Deaths Across Europe Rose 30% Over Decade, with Sharper Increase Among Women

A study published in The Lancet found over 2.5 million sudden deaths—natural unexpected deaths occurring within one hour of symptom onset—occurred across 26 European countries from 2010 to 2020, representing a 30% increase with a disproportionately sharper rise among women.

Apr 25, 2026·1 source
00
Apr 19, 2026

American College of Physicians Issues New Mammography Screening Guidelines for Women

New guidance recommends all average-risk women ages 50-74 receive biennial screening mammography for breast cancer, with individualized decision-making for women ages 40-49.

Apr 19, 2026·1 source
00
Apr 18, 2026

Folic Acid Supplementation Before Pregnancy Halves Birth Defect Risk in Women Taking Antiseizure Medication

Study finds women with epilepsy taking antiseizure medication who initiate high-dose folic acid before pregnancy have approximately 45% reduced risk of major congenital anomalies in their children.

Apr 18, 2026·1 source
00
Apr 14, 2026

Radon Gas Exposure Linked to Increased Ovarian Cancer Risk

New research identifies radon, an invisible radioactive gas, as a risk factor for ovarian cancer in women, adding to known health hazards of the environmental contaminant.

Apr 14, 2026·1 source
00

APOE4 Alzheimer's Gene Found to Weaken Bone Quality in Women

Scientists at the Buck Institute and UC San Francisco discovered that APOE4, the most common genetic risk factor for Alzheimer's disease, causes bone quality deterioration in women, revealing an unexpected connection between neurological and skeletal health.

Apr 14, 2026·1 source
00
Apr 13, 2026

Reversible Male Contraceptive Shows Promise in Temporarily Stopping Sperm Production

Cornell scientists achieved a major breakthrough in developing a reversible male contraceptive that can temporarily halt sperm production, representing a significant advance in male birth control options.

Apr 13, 2026·2 sources
00
Apr 11, 2026

Estrogen Patch Shortages Reported Due to Surging Demand for Menopause Treatment

Growing demand for estrogen patches to relieve menopause symptoms has led to widespread shortages across pharmacies, forcing women to search multiple locations or switch medications.

Apr 11, 2026·1 source
00
Apr 9, 2026

HRT Patches Treat Prostate Cancer as Effectively as Standard Injections with Fewer Side Effects

A large UK trial published in the New England Journal of Medicine found that women's hormone replacement therapy patches can treat prostate cancer just as effectively as standard hormone injections but with fewer severe side effects.

Apr 9, 2026·1 source
00

Top claims

  • ▪Biomarker tests collected during life showed that women using estrogen-only hormone therapy had amyloid biomarker levels in blood and spinal fluid consistent with less amyloid accumulating in the brain
  • ▪Among study participants whose brains were examined after death, 18% of estrogen-only hormone therapy users showed no signs of Alzheimer's disease at autopsy, compared to 10% of non-users
  • ▪After accounting for factors like age, education, genetics, race, and hypertension, estrogen-only hormone therapy use was associated with 35% lower odds of showing signs of Alzheimer's disease at autopsy

Topics

Alzheimer's diseaseAlzheimer’s & dementiaMental healthAging (Biology)Reproductive HealthDrug Approval and Clinical TrialsPregnancy healthBrain plasticityNeuroplasticityPublic healthcareEuropean UnionDrug safetyPublic Health and SafetyCardiovascular healthLifestyle, Wellness and NutritionEvidence based supplementationSupplementation fundamentalsEnvironmental and Occupational HealthEnvironmental regulationBiomarkers & bloodwork testingAging biology expertsAge related cognitive declineBiohacking & optimizationBiohacking fundamentalsHormone optimizationSupplement regulationHealth

Related entities

EstrogenHormone therapyEuropePreventive medicineFolic acidEpilepsy Ovarian canceAlzheimer's diseaseGeneticProceedings of the National Academy of SciencesUnited StatesUnited Kingdom